Adaptive, Modular, and AI-Powered Implantable Systems for Personalized Medicine

A next-generation implantable system that integrates nanoporous, bicontinuous morphology devices with bio-responsive, self-healing materials, real-time biosensors, and AI-powered controllers to deliver personalized, adaptive, and targeted biotherapeutic agents for treating damaged or degenerated tissues.

The original implantable cellular and biotherapeutic agent delivery canister patent has limitations in terms of its fixed, non-adaptive design and lack of real-time monitoring and control capabilities. The new inventive concept addresses these limitations by envisioning a modular, implantable system that can adapt to in vivo conditions, monitor performance in real-time, and optimize delivery protocols based on patient-specific data.

The new inventive concept comprises multiple, interconnected nanoporous modules that can be customized to release specific biotherapeutic agents in a controlled, spatiotemporal manner. Each module is designed with a nanoporous structure and a bio-responsive, self-healing material that adapts to in vivo conditions. The system includes a wearable, artificial intelligence-powered controller that optimizes the delivery protocol based on real-time patient data, and a real-time biosensor that monitors the device's performance. The system can be further personalized using patient-specific, 3D-printed structures with tailored nanoporous morphology and machine learning-based algorithms that predict optimal therapeutic dosing and timing.

The new claims introduce the concept of adaptive, modular, and AI-powered implantable systems that can respond to in vivo conditions, monitor performance in real-time, and optimize delivery protocols based on patient-specific data. These features are not present in the original patent and represent a significant departure from the state of the art.

Alternative embodiments of the inventive concept could include the use of different nanoporous materials, varying module geometries, and alternative AI-powered control systems. Additionally, the system could be adapted for use in different therapeutic areas, such as cancer treatment or gene therapy.

The new inventive concept has significant commercial potential in the personalized medicine market, with potential applications in regenerative medicine, cancer treatment, and gene therapy. The market for implantable devices is projected to grow significantly in the coming years, driven by increasing demand for personalized and targeted therapies.